NeuroOne Medical Technologies (NASDAQ:NMTC) vs. Tauriga Sciences (OTCMKTS:TAUG) Head-To-Head Comparison

NeuroOne Medical Technologies (NASDAQ:NMTC) and Tauriga Sciences (OTCMKTS:TAUG) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

Analyst Ratings

This is a summary of current ratings for NeuroOne Medical Technologies and Tauriga Sciences, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroOne Medical Technologies	1	1	3	0	2.40
Tauriga Sciences	0	0	0	0	0.00

NeuroOne Medical Technologies currently has a consensus price target of $11.67, indicating a potential upside of 283.77%. Given NeuroOne Medical Technologies’ stronger consensus rating and higher possible upside, equities analysts clearly believe NeuroOne Medical Technologies is more favorable than Tauriga Sciences.

Profitability

This table compares NeuroOne Medical Technologies and Tauriga Sciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeuroOne Medical Technologies	-68.35%	-99.43%	-70.40%
Tauriga Sciences	N/A	N/A	N/A

Insider & Institutional Ownership

16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 11.8% of NeuroOne Medical Technologies shares are owned by company insiders. Comparatively, 3.5% of Tauriga Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Earnings and Valuation

This table compares NeuroOne Medical Technologies and Tauriga Sciences”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroOne Medical Technologies	$12.10 million	2.19	-$3.61 million	($0.85)	-3.58
Tauriga Sciences	N/A	N/A	N/A	N/A	N/A

Tauriga Sciences has lower revenue, but higher earnings than NeuroOne Medical Technologies.

Summary

NeuroOne Medical Technologies beats Tauriga Sciences on 6 of the 9 factors compared between the two stocks.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

About Tauriga Sciences

Tauriga Sciences, Inc. produces and sells cannabidiol infused chewing gum under the Tauri-Gum brand name. It also develops anti-nausea products; and skin care products include CBD facemasks; CBD daily moisturizer; CBD anti-wrinkle dream, hand, and foot cream with hemp seed oil; CBD massage and body oil; CBD body revive roll-on; CBD transdermal patch; and CBD body spray. In addition, the company offers rainbow deluxe sampler pack, CBD non-GMO dietary supplements, and CBD scented bath bombs. It sells its products through e-commerce, distributors, and wholesale channels. The company has a collaboration agreement with Aegea Biotechnologies, Inc. to develop a rapid, multiplexed COVID-19 (novel coronavirus) test. Tauriga Sciences, Inc. was founded in 2001 and is headquartered in Wappingers Falls, New York.